Logo
Nazad
S. Pierson, M. Lim, G. Srkalović, Joshua D. Brandstadter, Mateo Sarmiento Bustamante, S. Shyamsundar, Natalie A Mango, Criswell Lavery, Bridget Austin, D. Alapat, M. Lechowicz, A. Bagg, Honzhe Li, C. Casper, F. van Rhee, D. Fajgenbaum
4 1. 9. 2023.

Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomes

Key Points • Fifty-two percent of patients with iMCD treated with siltuximab with/without corticosteroids achieved response.• Corticosteroids alone are not effective in iMCD symptom management.


Pretplatite se na novosti o BH Akademskom Imeniku

Ova stranica koristi kolačiće da bi vam pružila najbolje iskustvo

Saznaj više